II
UTHR icon

Inspire Investing’s United Therapeutics UTHR Stock Holding History

Inspire Investing’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.72M Buy
13,022
+958
+8% +$477K 0.45% 38
2025
Q4 		$5.88M Buy
12,064
+4,739
+65% +$2.21M 0.53% 34
2025
Q3 		$3.07M Buy
7,325
+921
+14% +$310K 0.3% 67
2025
Q2 		$1.84M Sell
6,404
-710
-10% -$212K 0.2% 123
2025
Q1 		$2.19M Sell
7,114
-1,237
-15% -$424K 0.26% 98
2024
Q4 		$2.95M Buy
8,351
+1,286
+18% +$473K 0.33% 60
2024
Q3 		$2.53M Sell
7,065
-3,151
-31% -$1.06M 0.26% 82
2024
Q2 		$3.25M Buy
10,216
+2,936
+40% +$777K 0.38% 51
2024
Q1 		$1.67M Buy
7,280
+1,092
+18% +$246K 0.17% 147
2023
Q4 		$1.36M Sell
6,188
-2,071
-25% -$477K 0.15% 164
2023
Q3 		$1.87M Buy
8,259
+3,619
+78% +$834K 0.24% 96
2023
Q2 		$1.02M Buy
4,640
+464
+11% +$103K 0.12% 179
2023
Q1 		$935K Hold
4,176
– – 0.12% 151
2022
Q4 		$1.16M Sell
4,176
-1,619
-28% -$409K 0.15% 137
2022
Q3 		$1.21M Buy
5,795
+1,123
+24% +$251K 0.17% 116
2022
Q2 		$1.1M Sell
4,672
-1,069
-19% -$217K 0.15% 125
2022
Q1 		$1.03M Buy
5,741
+593
+12% +$113K 0.12% 162
2021
Q4 		$1.11M Sell
5,148
-2,100
-29% -$412K 0.13% 152
2021
Q3 		$1.34M Sell
7,248
-888
-11% -$175K 0.17% 148
2021
Q2 		$1.46M Buy
8,136
+1,202
+17% +$229K 0.19% 109
2021
Q1 		$1.16M Buy
6,934
+5,260
+314% +$877K 0.18% 114
2020
Q4 		$254K Buy
+1,674
New +$220K 0.06% 524
2020
Q3 		– Sell
-1,984
Closed -$240K – 574
2020
Q2 		$240K Sell
1,984
-507
-20% -$57K 0.08% 309
2020
Q1 		$236K Buy
+2,491
New +$237K 0.09% 312

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Inspire Investing's UTHR Position: Q1 2026 in Review

Inspire Investing increased its United Therapeutics (UTHR) stake by 7.9% in Q1 2026, buying an estimated $477K and bringing the position to 13,022 shares worth $7.72M. The position accounts for 0.45% of the portfolio, ranked #38.

Inspire Investing first reported a position in UTHR in Q1 2020 and has held it in 24 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Inspire Investing held 13,022 shares of United Therapeutics worth $7.72M as of Q1 2026.
  • Inspire Investing bought 958 United Therapeutics shares in Q1 2026, an estimated $477K.
  • United Therapeutics made up 0.45% of Inspire Investing's portfolio in Q1 2026, its #38 holding.
  • Inspire Investing first reported a position in United Therapeutics in Q1 2020 and has held it in 24 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.